FindTrial
Sign In

Effect of Magnesium Sulfate on Muscle Strength in Patients with Myasthenia Gravis

Effect of Magnesium Sulfate on Muscle Strength in Patients with Myasthenia Gravis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017696
Enrollment
Unknown
Registered
2018-08-10
Start date
2016-07-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia Gravis

Interventions

Group A:Magnesium Sulfate
Group B:Normal saline

Sponsors

The University of Hong Kong-Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ASA II-III, aged 18 to 60 years old, body weight 40 ~ 100kg, gender is not limited, elective thoracoscopic thymoma resection patients.

Exclusion criteria

Exclusion criteria: Preoperative patients were excluded if the history of local anesthetic allergy, heart failure, hypertension, liver disease, diabetes, obesity (BMI> 30kg / m2), renal insufficiency, electrolyte imbalance, preoperative muscle weakness drug control Poor people.

Design outcomes

Primary

MeasureTime frame
TOF;Rocuronium dose;—

Countries

China

Contacts

Public ContactShoujun Fei

The University of Hong Kong-Shenzhen Hospital

feisj@hku-szh.org+86 18682240150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026